← Back to Search

Procedure

Lung Resection with Lung Resection Marker Locator Kit for Lung Disease

Phase 1 & 2
Waitlist Available
Research Sponsored by Navigation Sciences, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 day
Awards & highlights

Study Summary

This trial is for people with lung nodules who are eligible for surgery. The Lung Resection Marker Locator Kit will help the surgeon find and remove the nodule during surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To compare the measurements from the J-bar fiducial to the first staple line obtained by the device in vivo to that performed in the frozen section room on the lung specimen obtained (which includes both the J bar and the staple line).
Secondary outcome measures
demonstrate safe surgical remove of lung nodule
time required for device placement
whether coefficient is needed

Trial Design

1Treatment groups
Experimental Treatment
Group I: VATS resection with J-barExperimental Treatment1 Intervention
Each patient with a lung nodule meeting criteria will undergo a lung resection which could be one of three approaches: iVATS with Dyna-CT, VATS, or open. Each approach will use a the experimental device the Lung Resection Marker Locator Kit

Find a Location

Who is running the clinical trial?

Navigation Sciences, Inc.Lead Sponsor

Media Library

Lung Resection with Lung Resection Marker Locator Kit (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04702165 — Phase 1 & 2
Lung Disease Research Study Groups: VATS resection with J-bar
Lung Disease Clinical Trial 2023: Lung Resection with Lung Resection Marker Locator Kit Highlights & Side Effects. Trial Name: NCT04702165 — Phase 1 & 2
Lung Resection with Lung Resection Marker Locator Kit (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04702165 — Phase 1 & 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are applications for participation still being accepted for this research endeavor?

"Clinicaltrials.gov states that this trial, first posted on June 3rd 2021 and last updated September 27th 2022, is not presently enrolling patients. However, there are 284 other active studies currently seeking participants to join their trials."

Answered by AI
~7 spots leftby Apr 2025